Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial
A randomized phase 2 trial published in Nature Medicine examined talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer. No trial results or efficacy data are provided in the available information.
AI summary · generated only from source feed metadata; consult originalSource published
Published here
views4
Original source
Nature Medicine
Media report · consult original reporting
Read the original ↗https://www.nature.com/articles/s41591-026-04671-5Original headline
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial
AI bilingual edit · consult originalHeadlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.